ACL Australian Clinical Labs Limited
Healthcare · Diagnostics & Research
· website
· 4,700 employees
$2.35
52wk 1.83 – 2.97
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Australian Clinical Labs Limited
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$438.32M
P/E (trailing)
16.79
P/E (forward)
12.98
EPS (trailing)
0.14
Dividend yield
5.4%
Payout ratio
88.5%
Beta
0.81
EV / EBITDA
9.16
Price / Book
2.99
ROE
16.7%
Operating margin
7.7%
Net margin
3.6%
Total cash
$23.14M
Total debt
$315.11M
Current ratio
0.59
Debt / Equity
2.09
Free cash flow
$168.14M
Avg volume
564,050
Latest annual results
(FY ending 30 Jun 2025)
- Revenue$736.15M
- Gross profit$607.90M
- Operating income$62.88M
- Net income$32.43M
- Diluted EPS0.17
- Free cash flow$174.39M
- Net debt$268.94M